| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |